INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 430m ago
HOUSE PTR30m ago
SEC 13F30m ago
ROBINHOOD CHAIN30m ago
Public company

ARWRARROWHEAD PHARMACEUTICALS, INC.

CIK 0000879407

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 4
Max Insider Score21
Connections6with evidence

ARWR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CG
Cohen Matthew GregoryDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Grant or award
A—
11.9K sh
Jun 15, 2026Jun 17, 2026
traded Jun 15, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Cohen Matthew GregoryDirector · Jun 17, 2026
  • ← Insider ofevidence
    Apel Daniel JosephChief Financial Officer · Jan 8, 2026
  • ← Insider ofevidence
    Hamilton James CChief Medical Officer · Jan 8, 2026
11
HC
Hamilton James CChief Medical Officer
ARWRARROWHEAD PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL
$750K
10.0K sh
Apr 23, 2026
Apr 24, 2026
traded Apr 23, 2026
+1d
SEC FORM 4

Evidence

21
AJ
Apel Daniel JosephChief Financial Officer
ARWRARROWHEAD PHARMACEUTICALS, INC.
Grant or award
A—
75.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

17
HC
Hamilton James CChief Medical Officer
ARWRARROWHEAD PHARMACEUTICALS, INC.
Grant or award
A—
75.0K sh
Jan 6, 2026Jan 8, 2026
traded Jan 6, 2026
+2dSEC FORM 4

Evidence

12
VV
Vakiener VictoriaDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$186K
2,799 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC FORM 4

Evidence

15
VV
Vakiener VictoriaDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$359K
5,281 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC FORM 4

Evidence

12
VV
Vakiener VictoriaDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$134K
1,960 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC FORM 4

Evidence

13
LH
Lu HongboDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Grant or award
A—
7,819 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence

17
VV
Vakiener VictoriaDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Grant or award
A—
7,819 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Vakiener VictoriaDirector · Dec 18, 2025
  • ← Insider ofevidence
    Lu HongboDirector · Dec 18, 2025